Insulin Therapy in People Who Have Dysglycemia and...

Insulin Therapy in People Who Have Dysglycemia and Type 2 Diabetes Mellitus: Can It Offer Both Cardiovascular Protection and Beta-Cell Preservation?

Abstract

Mounting evidence suggests that insulin therapy may reduce risk for CV events while preserving beta-cell function, and several continuing long-term CV trials are testing these hypotheses explicitly.

Authors

Gerstein HC; Rosenstock J

Journal

Endocrinology and Metabolism Clinics of North America, Vol. 34, No. 1, pp. 137–154

Publisher

Elsevier

Publication Date

January 1, 2005

DOI

10.1016/j.ecl.2004.11.002

ISSN

0889-8529

Associated Experts

Hertzel Chaim Gerstein

Professor, FHSMED

Visit profile

Labels